Also trades as: 6127.HK (HKSE) · $vol 26M
603127.SS SHH
Joinn Laboratories(China)Co.,Ltd.
1W: +6.9%
1M: +6.1%
3M: +24.4%
YTD: +32.1%
1Y: +63.4%
3Y: +77.2%
5Y: -24.2%
¥49.30 ($7.35)
+4.48 (+10.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$339M
-45.6% ▼
5Y CAGR: +18.0%
Capital Expenditures
$269M
-39.8% ▼
5Y CAGR: +16.3%
Free Cash Flow
$70M
-83.8% ▼
5Y CAGR: +26.7%
Dividends Paid
$120M
+44.2% ▲
Buybacks
$108M
+5.0% ▲
Net Change in Cash
-$1.9B
-4021.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $314M | $556M | $1.1B | $392M | $70M |
| Depreciation & Amort. | $61M | $96M | $121M | $130M | $130M |
| Stock-Based Comp. | $30M | $24M | $10M | $6M | $0 |
| Change in Working Capital | $86M | $159M | $182M | -$127M | $41M |
| Other Non-Cash Items | -$757K | $22M | -$420M | $269M | $98M |
| Operating Cash Flow | $428M | $686M | $971M | $648M | $339M |
| — Investing Activities — | |||||
| Capital Expenditures | -$149M | -$237M | -$275M | -$193M | -$269M |
| Acquisitions (Net) | $186K | $10M | -$1.7B | -$90M | $0 |
| Investment Purchases | -$444M | -$2.6B | -$1.1B | -$647M | -$5.1B |
| Investment Sales | $342M | $789M | $907M | $606M | $3.4B |
| Other Investing | -$4M | -$10M | -$13M | -$17M | $10M |
| Investing Cash Flow | -$255M | -$2.1B | -$2.2B | -$340M | -$2.0B |
| — Financing Activities — | |||||
| Net Debt Issuance | $4M | -$4M | -$3M | -$7M | -$29M |
| Stock Repurchased | $0 | -$655K | -$24M | -$114M | -$108M |
| Dividends Paid | -$55M | -$95M | -$137M | -$214M | -$120M |
| Other Financing | $14M | -$13M | $65M | -$27M | -$9M |
| Financing Cash Flow | -$37M | $5.3B | -$99M | -$362M | -$266M |
| Net Change in Cash | $128M | $3.8B | -$1.3B | -$46M | -$1.9B |
| Cash End of Period | $305M | $4.2B | $2.9B | $2.9B | $965M |
| Free Cash Flow | $279M | $448M | $696M | $430M | $70M |